UBE Corp
XMUN:UBE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
UBE Corp
XMUN:UBE
|
JP |
|
A
|
Alnylam Pharmaceuticals Inc
F:DUL
|
US |
Wall St Price Targets
UBE Price Targets Summary
UBE Corp
According to Wall Street analysts, the average 1-year price target for UBE is 19.14 EUR with a low forecast of 16.88 EUR and a high forecast of 22.65 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UBE's stock price target?
Price Target
19.14
EUR
According to Wall Street analysts, the average 1-year price target for UBE is 19.14 EUR with a low forecast of 16.88 EUR and a high forecast of 22.65 EUR.
What is the Revenue forecast for UBE Corp?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 0%.
What is the Gross Profit forecast for UBE Corp?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for UBE Corp?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 11 years is 3%.
What is the Pre-Tax Income forecast for UBE Corp?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for UBE Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 10%.
